<DOC>
	<DOCNO>NCT00426010</DOCNO>
	<brief_summary>We propose measure effect placebo elimination well `` balance placebo '' design , determine interaction active drug , explore whether placebo exerts part effect pharmacokinetics level .</brief_summary>
	<brief_title>Measuring Placebo Effect Elimination Investigating Mechanism Action</brief_title>
	<detailed_description>Placebos use century medical practice . However , continue controversy regard effectiveness mechanisms action . The result study expect understanding widely use medical intervention , i.e. , placebo , maximize potential beneficial effect . It also help assess appropriateness measure placebo effect elimination , important ethical implication relation design randomize clinical trial . Comparison : caffeine v placebo . Dependent variables:4 hour area curve ( AUC ) pharmacodynamics endpoint well pharmacokinetics endpoint subgroup .</detailed_description>
	<mesh_term>Caffeine</mesh_term>
	<criteria>Males nonpregnant female 18 40 year age least high school education . Exclusion criterion : Include evidence clinically relevant deviation normal health ( may affect endpoint , make ingestion caffeine dangerous , affect pharmacokinetics/pharmacodynamics caffeine ) , Pregnancy , Poor venous access , Hypertension ( 140/90 ) , Heart disease , History panic attack , Average daily caffeine consumption 300 less 100 mg , Smoking , Alcohol abuse , Taking medication birth control bill ( include overthecounter drug ) within one week start study , Hypersensitivity caffeine relate compound , Hemoglobin le 13 gm/L , recent ( one week ) acute illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Placebo effect</keyword>
	<keyword>Caffeine</keyword>
	<keyword>Systolic BP</keyword>
	<keyword>VAS</keyword>
</DOC>